Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S391-S408 , July 2009

Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis

  • Suresh Vedantham, MD

      Affiliations

    • Department of Radiology, Mallinckrodt Institute of Radiology, St. Louis, Missouri
    • Corresponding Author InformationAddress correspondence to S.V., c/o Tricia McClenny, Society of Interventional Radiology, 3975 Fair Ridge Dr, Suite 400 North, Fairfax, VA 22033
    • ,
  • Clement J. Grassi, MD

      Affiliations

    • Department of Radiology, Lahey Clinic Medical Center, Burlington, Massachusetts
    • ,
  • Hector Ferral, MD

      Affiliations

    • Department of Radiology, Rush University Medical Center, Chicago, Illinois
    • ,
  • Nilesh H. Patel, MD

      Affiliations

    • RUSH Presbyterian-St Luke's Medical Center, Chicago, Illinois
    • ,
  • Patricia E. Thorpe, MD

      Affiliations

    • University of Iowa School of Medicine, Iowa City, Iowa
    • ,
  • Vittorio P. Antonacci, MD

      Affiliations

    • Charlotte Radiology, Charlotte, North Carolina
    • ,
  • Bertrand M. Janne d'Othée, MD

      Affiliations

    • Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • ,
  • Lawrence V. Hofmann, MD

      Affiliations

    • Department of Interventional Radiology, Johns Hopkins Hospital, Baltimore, Maryland
    • ,
  • John F. Cardella, MD

      Affiliations

    • Department of Radiology, University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • Sanjoy Kundu, MD

      Affiliations

    • Department of Medical Imaging, Scarborough General Hospital, Richmond Hill, Canada
    • ,
  • Curtis A. Lewis, MD, MBA

      Affiliations

    • Manuel Maloof Imaging Center, Atlanta, Georgia
    • ,
  • Marc S. Schwartzberg, MD

      Affiliations

    • Private Practice, Mt Dora, Florida
    • ,
  • Robert J. Min, MD

      Affiliations

    • Cornell Medical Imaging, New York, New York
    • ,
  • David Sacks, MD

      Affiliations

    • The Reading Hospital and Medical Center, Reading, Pennsylvania
    • ,
  • Technology Assessment Committee of the Society of Interventional Radiology

Received 21 September 2005 ,Accepted 12 November 2005.

References 

  1. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology. 1994;191:487–494
  2. Sharafuddin MJ, Sun S, Hoballah JJ, et al. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol. 2003;14:405–423
  3. Porter JM, Rutherford RB, Clagett GP, et al. Reporting standards in venous disease. J Vasc Surg. 1988;8:172–181
  4. Porter JM, Moneta GL, et al. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21:635–645
  5. Rutherford RB, Padberg FT, Comerota AJ, et al. Venous outcomes assessment. In:  Gloviczki P,  Yao JST editor. Handbook of Venous Disorders, 2nd ed: Guidelines of the American Venous Forum. Great Britain: Arnold; 2001;p. 497–508
  6. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–1252
  7. Sacks D, Marinelli DL, Martin GL, et al. General principles for evaluation of new interventional technologies and devices. J Vasc Interv Radiol. 2003;14:S391–S394
  8. Patel N, Sacks D, Patel RI, et al. SIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol. 2003;14:S453–S465
  9. Piccioli A, Prandoni P, Goldhaber SZ. Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. Am Heart J. 1996;132:1010–1014
  10. Goldhaber SZ. Epidemiology of pulmonary embolism and deep vein thrombosis. In:  Bloom A,  Forbes C,  Thomas D, et al. editor. Haemostasis and Thrombosis. 3rd ed.. New York: Churchill Livingstone; 1994;p. 1327–1333
  11. Partsch H, Kechavarz B, Mostbeck A, et al. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin. J Vasc Surg. 1996;24(5):774–782
  12. Caggiati A, Bergan JJ, Gloviczki P, et al. International Interdisciplinary Consensus Committee on Venous Anatomical Terminology Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application. J Vasc Surg. 2005;41:719–724
  13. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation. 1973;48:839–846
  14. Prandoni P, Lensing AW, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955–960
  15. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism: an overview. Chest. 1986;89:374S–383S
  16. Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bed rest. Br J Surg. 1957;45:209–236
  17. Weill-Engerer S, Meaume S, Lahlou A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J Am Geriatr Soc. 2004;52:1299–1304
  18. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  19. Buller HR, Hull RD, Hyers TM, et al. Antithrombotic therapy for venous thromboembolic disease (The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy). Chest. 2004;126:401S–428S
  20. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–153
  21. Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405–418
  22. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341:801–806
  23. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy: Duration of Anticoagulation Study Group. Am J Med. 1998;104:332–338
  24. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993–997
  25. Simioni P, Prandoni P, Lensing AW, et al. The risk of recurrent venous thromboembolism in patients with an Arg506° Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med. 1997;336:399–403
  26. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138:128–134
  27. Andersen BS, Steffensen FH, Sorensen HT, et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium—an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol. 1998;77:170–173
  28. Krishnamurthy P, Martin CB, Kay HH, et al. Catheter-directed thrombolysis for thromboembolic disease during pregnancy: a viable option. J Matern Fetal Med. 1999;8:24–27
  29. Koster T, Small RA, Rosendaal FR, Helmerhorst FM. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties. J Intern Med. 1995;238:31–37
  30. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–416
  31. Vedantham S, Vesely TM, Parti N, et al. Endovascular recanalization of the thrombosed filter-bearing inferior vena cava. J Vasc Interv Radiol. 2003;14:893–903
  32. Meissner MN, Strandness DE, et al. Pathophysiology and natural history of deep venous thrombosis. In:  Rutherford RB editors. Vascular Surgery. 5th ed.. Philadelphia: WB Saunders; 2000;p. 1920–1937
  33. Mewissen WM, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49
  34. Keats A. The ASA Classification of physical status—a recapitulation. Anesthesiology. 1978;49:233–236
  35. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–762
  36. Prandoni P. Below-knee compression stockings for prevention of the post-thrombotic syndrome: a randomized study. Pathophysiol Haemost Thromb. 2002;32(suppl 2):72
  37. Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med. 2001;161:2105–2109
  38. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127–1131
  39. Brockman SK, Vasko JS. Phlegmasia cerulea dolens. Surg Gynecol Obstet. 1965;121:1347–1356
  40. Rutherford RB, Padberg FT, Comerota AJ, et al. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31:1307–1312
  41. Meissner MH, Natiello C, Nicholls SC. Performance characteristics of the venous clinical severity score. J Vasc Surg. 2002;36:889–895
  42. Ricci MA, Emmerich J, Callas PW, et al. Evaluating chronic venous disease with a new venous severity scoring system. J Vasc Surg. 2003;38:909–915
  43. Villalta S, Bagatella P, Piccioli A, et al. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Hemostatis. 1994;24(Suppl 1):157
  44. Ziegler S, Schillinger M, Maca TH, et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res. 2001;101:23–33
  45. Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996;5:539–554
  46. Mathias SD, Prebil LA, Putterman CG, et al. A health-related quality of life measure in patients with deep vein thrombosis: a validation study. Drug Inform J. 1999;33:1173–1187
  47. Lamping DL, Abenhaim L, Kurz X, et al. Measuring quality of life and symptoms in chronic venous disorders of the leg: development and psycho-metric evaluation of the VEINESQOL/VEINES-SYM questionnaire. Qual Life Res. 1998;7:621–622
  48. Lamping DL, Schroter S, Kurz X, et al. Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality-of-life. J Vasc Surg. 2003;37:410–419
  49. Kahn SR, M'lan CE, Lamping DL, et al. VEINES Study Group Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study. J Vasc Surg. 2004;39:823–828
  50. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 2004;239:118–126
  51. Franks PJ, Moffatt CJ. Health related quality of life in patients with venous ulceration: use of the Nottingham health profile. Qual Life Res. 2001;10:693–700
  52. O'Donnell TF, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects on an iliofemoral venous thrombosis. J Surg Res. 1977;22:483–488
  53. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med. 2001;110:515–519
  54. Kamida CB, Kistner RL, Eklof B, Masuda EM. Lower extremity ascending and descending phlebography. In:  Gloviczki P,  Yao JST editor. Handbook of Venous Disorders, 2nd ed: Guidelines of the American Venous Forum. Great Britain: Arnold; 2001;p. 132–139
  55. Douglas MG, Sumner DS. Duplex scanning for deep vein thrombosis: has it replaced both phlebography and non-invasive testing?. Semin Vasc Surg. 1996;9:3–12
  56. Tick LW, Ton E, van Voorthuizen T, et al. Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test. Am J Med. 2002;113:630–635
  57. Prandoni P, Bernardi E, Tormene D, et al. Diagnosis of recurrent deep vein thrombosis. Semin Vasc Med. 2001;1:55–60
  58. Elias A, LeCorff G, Bouvier JL. Value of real-time ultrasound imaging in the diagnosis of deep vein thombosis of the lower limbs. Int Angiol. 1987;6:175–182
  59. Mitchell DC, Grasty MS, Stebbings WSL, et al. Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis. Br J Surg. 1991;78:611–613
  60. Roh BS, Park KH, Kim EA, et al. Prognostic value of CT before thrombolytic therapy in iliofemoral deep venous thrombosis. J Vasc Interv Radiol. 2002;13:71–76
  61. Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002;136:89–98
  62. Rigas A, Vomvoyannis A, Giannoulis K, et al. Measurement of femoral vein pressure in oedema of the lower extremities: report of 50 cases. J Cardiovasc Surg (Torino). 1971;12:411–416
  63. Negus D, Cockett FB. Femoral vein pressures in post-phlebitic iliac vein obstruction. Br J Surg. 1967;54:522–525
  64. Calnan JS, Kountz S, Pentecost BL, et al. Venous obstruction in the aetiology of lymphoedema praecox. Br J Med. 1964;2:221–226
  65. Taraki C, Hobson RW. Indirect noninvasive tests (plethysmography). In:  Gloviczki P,  Yao JST editor. Handbook of Venous Disorders, 2nd ed: Guidelines of the American Venous Forum. Great Britain: Arnold; 2001;p. 105–109
  66. Cragg AH. Lower extremity deep venous thrombolysis: a new approach to obtaining venous access. J Vasc Interv Radiol. 1996;7:283–288
  67. Ward AS, Andaz SK, Bygrave S. Peripheral thrombolysis with tissue plasminogen activator: results of two treatment regimens. Arch Surg. 1994;129:861–865
  68. Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36(4):1336–1343
  69. Becker GJ, Rabe FE, Richmond BD, et al. Low-dose fibrinolytic therapy: results and new concepts. Radiology. 1983;148:663–670
  70. Chang R, Cannon RO, Chen CC, et al. Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol. 2001;12:247–252
  71. Sullivan KL, Gardiner GA, Shapiro MJ, et al. Acceleration of thrombolysis with a high-dose trans-thrombus bolus technique. Radiology. 1989;173:805–808
  72. Bookstein JJ, Fellmeth B, Roberts A, et al. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR Am J Roentgenol. 1989;152:1097–1100
  73. Vedantham S, Vesely TM, Parti N, et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol. 2002;13:1001–1008
  74. Morgan R, Belli AM. Percutaneous thrombectomy: a review. Eur Radiol. 2002;12(1):205–217
  75. Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. J Vasc Interv Radiol. 2003;14:729–733
  76. Vedantham S, Vesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2004;15:565–574
  77. Eklof B, Kistner RL. Is there a role for thrombectomy in iliofemoral venous thrombosis?. Semin Vasc Surg. 1996;9:34–45
  78. Plate G, Eklof B, Norgren L, et al. Venous thrombectomy for iliofemoral venous thrombosis: 10-year results of a prospective randomized study. Eur J Vasc Endovasc Surg. 1997;14:333–343
  79. Epstein AE, Hallstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction (The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST)). JAMA. 1993;270:2451–2455
  80. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol. 2002;13:959–974
  81. Sacks D, Marinelli DL, Martin LG, Spies JB, et al. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14:S395–S404
  82. Marder VJ, Soulen RL, Arichartakarn V, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med. 1977;89:1018–1029
  83. Mattos MA, Sumner DS. Direct noninvasive tests (duplex scan) for the evaluation of chronic venous obstruction and valvular incompetence. In:  Gloviczki P,  Yao JST editor. Handbook of Venous Disorders, 2nd ed: Guidelines of the American Venous Forum. Great Britain: Arnold; 2001;p. 120–131
  84. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand. 1982;211:65–68
  85. Elliot MS, Immelman EJ, Jeffery P. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838–843
  86. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144–1148
  87. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–109
  88. Eisenberg JM. Clinical economics: a guide to the economics of clinical practices. JAMA. 1989;262:2878–2886
  89. Powe NR. Economic and cost-effectiveness investigations of radiologic practices. Radiology. 1994;192:11–18
  90. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials (The CONSORT Statement). JAMA. 1996;276:637–639
  91. Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–137

 N.H.P. is the holder of patents with Angiodynamics and is a medical advisor for US Biopsy/Promex. L.V.H. is a paid consultant for Bacchus Vascular and Talecris Biotherapeutics. He is also on the speaker bureau for Genentech. None of the other authors have identified a conflict of interest.

 This article first appeared in J Vasc Interv Radiol 2006; 17:417–434.

PII: S1051-0443(09)00334-0

doi: 10.1016/j.jvir.2009.04.034

Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S391-S408 , July 2009

Article Tools